eTheRNA Announces Research Agreement with Merck KGaA, Darmstadt, Germany to access mRNA technologies
eTheRNA immunotherapies NV (“eTheRNA”) is pleased to announce the start of a strategic partnership with Merck KGaA, Darmstadt, Germany with the signing of a Research Agreement. The partnership will investigate